Market Overview

U.S. Scar Treatment Market to 2023 by Type of Treatment, Type of Scar & End User -


The "U.S.
Scar Treatment Market by Type of Treatment, by Type of Scar, by End User
- Market Size, Share, Development, Growth, and Demand Forecast, 2013 -
report has been added to's

Global scar treatment market size is expected to reach $34.9 billion by

The market is mainly driven by rising prevalence of skin diseases,
technological advancements in dermatological devices, rise in the number
of road accidents, increasing number of surgical procedures performed,
increasing awareness among people about various scar treatments, and
surge in disposable income of general population leading to rise in
spending on personal care.

Globally, North America accounted for the largest share of the scar
treatment market, with 38.5% share in 2017. This is attributable to high
disposable income of general population in the region, which further
increases spending on personal care products. Moreover, the increasing
appearance consciousness among the North American population has also
led to rise in the adoption of technologically advanced products.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

Chapter 5. Global Market Size And Forecast

Chapter 6. North America Market Size And Forecast

Chapter 7. Europe Market Size And Forecast

Chapter 8. APAC Market Size And Forecast

Chapter 9. LATAM Market Size And Forecast

Chapter 10. Mea Market Size And Forecast

Chapter 11. Competitive Landscape

Chapter 12. Company Profiles

  • Hologic Inc.
  • Syneron Medical Ltd.
  • Beijing Toplaser Technology Company Limited
  • Avita Medical Limited
  • Mlnlycke Health Care Ab
  • Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
  • Smith & Nephew Plc
  • Revitol Corporation Inc.
  • Sonoma Pharmaceuticals Inc.
  • Cca Industries Inc.
  • Scarguard Labs Llc
  • Quantum Health
  • Valeant Pharmaceuticals International Inc.
  • Pacific World Corporation
  • Merz Pharma Gmbh & Co. Kgaa
  • Johnson & Johnson

For more information about this report visit

View Comments and Join the Discussion!